Identification of Seniors at Risk Score to Determine Geriatric Evaluations on Trauma Patients With Hip Fractures
Recommended Citation
Long TK, Booza SD, and Turner LN. Identification of Seniors at Risk Score to Determine Geriatric Evaluations on Trauma Patients With Hip Fractures. J Trauma Nurs 2023; 30(3):142-149.
Document Type
Article
Publication Date
5-1-2023
Publication Title
Journal of trauma nursing
Abstract
BACKGROUND: Trauma centers are confronted with rising numbers of geriatric trauma patients at high risk for adverse outcomes. Geriatric screening is advocated but not standardized within trauma centers.
OBJECTIVE: This study aims to describe the impact of Identification of Seniors at Risk (ISAR) screening on patient outcomes and geriatric evaluations.
METHODS: This study used a pre-/post-design to assess the impact of ISAR screening on patient outcomes and geriatric evaluations in trauma patients 60 years and older, comparing the periods before (2014-2016) and after (2017-2019) screening implementation.
RESULTS: Charts for 1,142 patients were reviewed. Comparing pre- to post-ISAR groups, the post-ISAR group with geriatric evaluations were older (M = 82.06, SD = 9.51 vs. M = 83.64, SD = 8.69; p = .026) with higher Injury Severity Scores (M = 9.22, SD = 0.69 vs. M = 9.38, SD = 0.92; p = .001). There was no significant difference in length of stay, intensive care unit length of stay, readmission rate, hospice consults, or in-hospital mortality. In-hospital mortality (n = 8/380, 2.11% vs. n = 4/434, 0.92%) and length of stay in hours (M = 136.49, SD = 67.09 vs. M = 132.53, SD = 69.06) down-trended in the post-group with geriatric evaluation.
CONCLUSION: Resources and care coordination efforts can be directed toward specific geriatric screening scores to achieve optimal outcomes. Varying results were found related to outcomes of geriatric evaluations prompting future research.
Medical Subject Headings
Humans; Aged; Length of Stay; Risk Assessment; Geriatric Assessment; Risk Factors; Hip Fractures; Retrospective Studies
PubMed ID
37144802
Volume
30
Issue
3
First Page
142
Last Page
149